Furthermore, FABP4 has been demonstrated to act as an adipokine for the development of insulin resistance in liver [10], suppression of cardiomyocyte contraction [13], inhibition of endothelial nitric oxide synthase in endothelial cells [14] and proliferation and migration of vascular smooth muscle cells [15]. The gene discussed is FABP4; the disease is Insulin resistance.